The Food and Drug Administration on Thursday issued an emergency use authorization for what it said is the first device that can detect COVID-19 in breath samples.
The InspectIR COVID-19 Breathalyzer is about the size of a piece of carry-on luggage, the FDA said, and can be used in doctor’s offices, hospitals and mobile testing sites. The test, which can provide results in less than three minutes, must be carried out under the supervision of a licensed health care provider.
Dr. Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, called the device “yet another example of the rapid innovation occurring with diagnostic tests for COVID-19.”
The FDA said the device was 91.2% accurate at identifying positive test samples and 99.3% accurate at identifying negative test samples.
“InspectIR expects to be able to produce approximately 100 instruments per week, which can each be used to evaluate approximately 160 samples per day,” the agency said. “At this level of production, testing capacity using the InspectIR COVID-19 Breathalyzer is expected to increase by approximately 64,000 samples per month.”
Andrea Miller, founder and CEO of Your Tango, discusses why the world is in a global relationship crisis and a loneliness epidemic that has accelerated dramatically, especially since the pandemic. "More people are working from home and so they're not getting in-person connection," she said.
The era of free Covid tests has officially come to an end, raising concerns about potential scams. Dan Geltrude, managing partner with Geltrude & Co., joined Cheddar News to explain the most affordable way to get tests and how to avoid fake and illegitimate tests.
A university professor broke a record for the longest time living underwater without depressurization this weekend at a Florida Keys lodge for scuba divers.
About 16 tornadoes hit America's heartland including Colorado, Kansas and Louisiana with no injuries reported, and the worst damage was registered in Oklahoma.
